Avadel Pharmaceuticals plc

DB:AWK1 Stock Report

Market Cap: €1.4b

Avadel Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:AWK1 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Jan 24Buy€26,622Thomas McHughIndividual2,000€13.31
28 Dec 23Sell€983,826Mark McCamishIndividual75,000€13.12
14 Aug 23Buy€26,478Thomas McHughIndividual2,000€13.24
11 Aug 23Sell€394,674Mark McCamishIndividual28,975€13.62
10 Aug 23Buy€119,827Gregory DivisIndividual10,000€11.98
10 Aug 23Buy€170,303Geoffrey GlassIndividual14,000€12.16
18 May 23Buy€168,188Eric EndeIndividual13,000€12.94
09 May 23Buy€33,679Linda PalczukIndividual2,500€13.47

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of AWK1?
Owner TypeNumber of SharesOwnership Percentage
Private Companies2,5720.00284%
Individual Insiders4,570,0225.05%
Hedge Funds12,563,26813.9%
General Public17,246,58419%
Institutions56,194,55262%

Dilution of Shares: Insufficient data to determine if shareholders have been diluted in the past year.


Top Shareholders

Top 25 shareholders own 74.2% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
24.6%
Janus Henderson Group plc
22,250,660€355.9m109%0.16%
7.67%
RTW Investments, LP
6,947,918€111.1m-2.64%1.84%
7.45%
Polar Capital Holdings Plc
6,751,782€108.0m49.6%0.46%
6.2%
Tontine Management, LLC
5,615,350€89.8m0%3.84%
4.52%
Vivo Capital, LLC
4,096,428€65.5m0%4.99%
4.1%
Kevin Kotler
3,716,242€59.4m-21.4%no data
2.67%
Wealth Effects LLC
2,416,326€38.6m0.29%13.48%
2.05%
Woodline Partners LP
1,852,412€29.6m-2.65%0.32%
1.81%
Cowen Inc,Private Banking and Investment Banking Investments
1,642,347€26.3m-29.8%1.18%
1.69%
Brandes Investment Partners, LP
1,533,614€24.5m5.86%0.2%
1.19%
Tang Capital Management, LLC
1,079,528€17.3m7.95%1.82%
1.07%
Samsara BioCapital LLC
967,527€15.5m0%2.75%
1.05%
Morgan Stanley, Investment Banking and Brokerage Investments
953,911€15.3m130%no data
0.93%
Tri Locum Partners LP
839,933€13.4m-14.6%5.99%
0.86%
Balyasny Asset Management L.P.
781,515€12.5m0%0.03%
0.73%
BioImpact Capital LLC
664,986€10.6m0.11%2.29%
0.73%
SEB Investment Management AB
658,660€10.5m5.14%0.02%
0.71%
Kennedy Capital Management LLC
645,874€10.3m-9.72%0.23%
0.69%
Renaissance Technologies LLC
625,106€10.0m-15.4%0.01%
0.68%
Citadel Advisors LLC
613,185€9.8m32.4%0.01%
0.66%
Knoll Capital Management
600,000€9.6m0%7.63%
0.66%
Modera Wealth Management, LLC
598,392€9.6m0.74%0.15%
0.54%
Goldman Sachs Group, Investment Banking and Securities Investments
487,251€7.8m34.8%no data
0.49%
Deutsche Asset & Wealth Management
440,000€7.0m0%no data
0.47%
DWS Investment Management Americas, Inc.
425,000€6.8m41.7%0.03%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.